Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-12-11
2000-12-26
Low, Christopher S. F.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 17, 530328, 530329, A61K 3808, C07K 706, C07K 714
Patent
active
061659789
ABSTRACT:
Methods and compositions based on chemical analogs of angiotensin II and analogs of angiotensin II fragments useful for accelerating wound healing in mammals.
REFERENCES:
patent: 5015629 (1991-05-01), DiZerega et al.
File Caplus on STN, No. 93:221038. Khosla et al. `Synthesis of Angiotensin Analogs to Produce Selective Biological Actions`, Pept. Chem. vol. 17, pp. 123-126, 1980.
File Caplus on STN, No. 77:147796. Novotny et al. `Pharmacological Effects of Some Angiotensin Analogs Substituted in Position 5`, Bratislav. Lek. Listy. vol. 52, No. 3, pp. 298-302, 1972.
Fermandjian, et al., "Conformation and Activity in Angiotensin II Peptides" Biopolymers, 1981, 20, 1971-1983, 1981.
Lintner, et al., "pH Titration Effects on the CD Spectra of Angiotensin II, Truncated Peptides and Other Analogues: Aromatic Region" FEBS Letters, 1975, 56 (2), 366-369, 1975.
Wade, J.D. et al., An O-Phosphotyrosine-Containing Analogue of Human Angiotensin II Exhibits Increased Serum Stability, Protein Peptide Letters, vol. 4 No. 2 pp. 87-90 1997.
Samanen, J., et al., Potent Angiotensin II Antagonists with Non-.beta. Branched Amino Acids in Position 5, J. Med. Chem. 1989, 32, 466-472.
Jorgensen, E.C., Angiotensin II Analogs, 6. Stereochemical Factors in the 5 Position Influencing Pressor Activity. Journal of Medicinal Chemistry, vol. 14, No. 10, Oct., 1971.
Ambuhl, et al. (1992), Effects of angiotensin analogues and angiotensin receptor antagonists on paraventricular neurones, Regulatory Peptides 38:111-120.
Bell, L. and J.A. Madri (1990), Influence of the angiotensin system on endothelial and smooth muscle cell migration, Am. J. Pathol. 137:7-12.
Bell, L., et al. (1992), Autocrine angiotensin system regulation of bovine aortic endothelial cell migration and plasminogen activator involves modulation of proto-oncogene pp6Oc-src expression, J. Clin. Invest. 89:315-20.
Brattstrom, A., et al. (1992), Neuropeptides within the nucleus tractus solitarii modulate the central cardiovascular control process, Progress in Brain Research 91:75.
Dzau, V.E., et al. (1989), Molecular mechanism of angiotensin in the regulation of vascular and cardiac growth, J. Mol. Cell Cardiol. 21 (Supple III):S7.
Fernandez, L.A., et al. (1985), Neovascularization produced by angiotensin II, J. Lab. Clin. Med. 105:141.
Gibbons, G.H., et al. (1992), Vascular smooth muscle cell hypertrophy vs hyperplasia, Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II, J. Clin. Invest. 90:456-61.
Greenhalgh, D.G., et al. (1990), PDGF and FGF simulate wound healing in the genetically diabetic mouse, Am. J. Pathol. 136:1235-46.
Hunt, T.K., et al., "Coagulation and macrophage stimulation of angiogenesis and wound healing," in The surgical wound, pp. 1-18, ed. F. Dineen & G. Hildrick-Smith (Lea & Febiger, Philadelphia: 1981).
Kawahara, Y., et al. (1988), Angiotensin II induces expression of the c-fos gene through protein kinase C activation and calcium ion mobilization in cultured vascular smooth muscle cells, BBRC 150:52-9.
Kimura et al. Changes in skin angiotensin II receptors in rats during wound healing. Biochem Biophys Res Commun 187:1083-90.
LeNoble, F.A.C., et al. (1991), Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo, Eur. J. Pharmacol. 195:305-6.
Lynch, S.E., et al. (1989), Growth factors in wound healing, J. Clin. Invest. 84:640-6.
Naftilan, A.J., et al. (1989), Induction of platelet-derived growth factor A-chain c-myc gene expression by angiotensin II in cultured rat vascular smooth muscle cells, J. Clin. Invest. 83:1419-24.
Nakahara, K., et al. (1992), Identification of three types of PDGF-A chain gene transcripts in rabbit vascular smooth muscle and their regulated expression during development and by angiotensin II, BBRC 184:811-8.
Osterriedes, W., et al. (1991), Role of angiotensin II injury-induced neointima formation in rats, Hypertension 18:Suppl II60-64.
Powell, J.S., et al. (1991), The proliferative response to vascular injury is suppressed by converting enzyme inhibition, J. Cardiovasc. Pharmacol. 16 (suppl 4):S42-9.
Taubman, M.B., et al. (1989), Angiotensin II induces c-fos mRNA in aortic smooth muscle, Role of Ca.sup.2+ mobilization and protein kinase C activation, J. Biol. Chem. 264:526-530.
Vatta, M.S., et al. (1992), Monophasic and biphasic effects of angiotensin II and III on norepinephrine uptake and release in rat adrenal medulla, Can. J. Physiol. Pharmacol. 70:821.
Viswanathan et al. 1992. Expression of angiotensin II AT2 receptors in the rat skin during experimental wound healing. Peptides 13:783-6.
Wolf, G., et al. (1992), Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured marine mesangial cells, Am. J. Pathol. 140:95-107.
Khosla et al., Peptide Chemistry 123-126, 1979.
Novotny et al. Bratislav Lek. Listy 52(3):298-302, 1969.
diZerega Gere S.
Rodgers Kathleen
Gupta Anish
Low Christopher S. F.
University of Southern California
LandOfFree
Wound healing composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Wound healing composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Wound healing composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-994872